Getzome 40 Getz treatment for stomach ulcer, duodenum (2 blisters x 7 tablets)

Dosage form Box of 2 blisters x 7 tablets
Specifications Omeprazol

Ingredient

Composition informationContent
Omeprazol40mg

Uses

Indications 2>

Getzome 40 drugs are indicated in the following cases:

Adults:

  • Treatment of duodenal ulcer.
  • Recurrent duodenal ulceration.
  • Treatment of stomach ulcers.
  • Refuensions of stomach ulcers.
  • H.pylori kill in patients with gastrointestinal ulcer combined with appropriate antibiotics.
  • Gastroesophageal reflux disease (GERD) without esophageal injury.

  • Treatment of stomach and duodenal ulcer due to nonsteroidal anti -inflammatory drugs (NSAIDs).
  • Preventive gastric and duodenal ulcer prevention in patients at risk.
  • Treatment of esophagitis caused by reflux.
  • Long -term control in patients healed esophagitis due to reflux.
  • Treatment of gastroesophageal reflux symptoms.
  • Zollinger syndrome - Ellison.
  • Children 1 year and older and ≥ 10kg:

  • Treatment of gastroesophageal reflux.
  • Combined with antibiotics in the treatment of duoden ulcer caused by H.pylori. Omeprazole inhibits the secretion of acid in the stomach through specialized inhibition of H+, K+ - Atpase on the proton pump of the wall of the wall. This inhibition depends on the dose and affecting both the basic secretion and the acid secretion due to stimulation regardless of the acid secretion.

    pharmacokinetics

    absorption and distribution

    omeprazole is an unstable acid and is taken or taken by oral in the form of melted particles in the intestine in the capsule. Omeprazole absorbs quickly but changes when used by oral, peak concentration in plasma is reached within 0.5 to 3.5 hours. The absorption of omeprazole is not influenced by food. Higher absorption after a long time of medication.

    Birth of Omeprazole is about 35%. After repeating the dose 1 time/day, bioavailability increases to about 60%. The ratio of cohesion with plasma protein is about 95%.

    Metabolism and excretion

    After absorbing Omeprazole is completely metabolized, mainly in the liver. CYP2C19 and CYP3A enzymes catalyzed most of the metabolic process. The metabolites are not active and excreted mostly through the urine and a less amount through the bile. About 77% of the metabolites are excreted in the urine and the rest through the feces. Selling time for plasma is about 0.5 to 3 hours.

  • Before taking Getzome 40 Getz treatment for stomach ulcer, duodenum (2 blisters x 7 tablets)

    How to use

    Take oral use.

    Dosage

    adults

    Treatment of duodenal ulcer

    The recommended dose in patients with progressive duodenal ulcer is Getzome 20 mg once a day. Most patients heal ulcers within two weeks. For patients who have not healed ulcers completely after the initial treatment, continue the treatment for two more weeks. In patients with poor duodenal ulcer, encourage 40 mg of Getzome once a day and effectively achieved within four weeks.

    recurrent duodenal ulcerative preventive

    Prevention of recurrent duodenal ulcer in negative patients with H.pylori or when it is impossible to eradicate H.pylori, the recommended dose is 20 mg of omeprazole per day. In some patients, the dose of 10 mg may be used. In the event of failure, the dose can be increased to 40 mg.

    Treatment of stomach ulcers

    The recommended dose is Getzome 20 mg daily. Most patients heal ulcers within 4 weeks. For patients who are not completely cured after the initial treatment, another 4 weeks will help heal the ulcer. In patients with poorly responded ulcers, the recommended dose is 40 mg of Getzome and can heal ulcers within 8 weeks.

    Refuensions of stomach ulcers

    Prevention of recurrence in patients with poorly responded stomach ulcers, the recommended getzome dose is 20 mg daily. If necessary, the dose can be increased to 40 mg Getzome per day.

    H.pylori kill in patients with gastrointestinal ulcer

    To kill H.pylori, when choosing antibiotics, it is necessary to consider the patient's tolerance, and must depend on the national, regional and local resistance model and the treatment time as instructed.

    Treatment regimen with 3 drugs

  • Getzome 20 mg + Clarithromycin 500 mg + Amoxicillin 1000 mg, 2 times/day for 1 week or Getzome 20 mg + Clarithromycin 250 mg (500 mg) + Metronidazole 400 mg (or 500 mg or Tinidazole 500 mg), 2 times/day for 1 week. Amoxicillin 500 mg and Metronidazole 400 mg (or 500 mg or Tinidazole 500 mg), 3 times a day for 1 week (both above).

    Treatment regimen with 2 drugs

    Getzome 20 mg twice daily or 40 mg once daily with Clarithromycin 500 mg/3 times a day for 14 days; If the ulcer appears during the beginning of the treatment, it may be necessary to increase the treatment time of Omeprazole 20 mg/day adds 14-18 days (single treatment) after completion of coordination treatment.

    Gastroesophageal reflux disease (GERD) has no esophageal injury

    Getzome 20 mg/day to 4 weeks.

    Treatment of peptic ulcer due to nonsteroidal anti -inflammatory drugs (NSAIDs)

    The recommended dose is Getzome 20 mg daily. Most patients heal ulcers within 4 weeks. For patients who do not heal the ulcer completely after initial treatment, often heals ulcers after 4 weeks of treatment.

    Peptic ulcer prevention in patients at risk

    To prevent stomach ulcers or duodenal ulcers in patients at risk (> 60 years old, with a stomach and duodenal ulcer, with a history of gastrointestinal bleeding), the recommended dose is Getzome 20 mg daily.

    Treatment of esophagitis due to reflux

    The recommended dose is Getzome 20 mg daily. Most patients heal ulcers within 4 weeks. For patients who do not heal the ulcer completely after initial treatment, often heals ulcers after 4 weeks of treatment.

    In patients with severe esophagitis, the recommended dose is 40 mg of Getzome daily and usually heals ulcers for 8 weeks.

    Long -term control in patients healed esophagitis due to reflux

    The recommended dose is Getzome 10 mg, if necessary, the dose can be increased to 20 - 40 mg daily.

    Symptomatic treatment in patients with gastroesophageal reflux

    The recommended dose is Getzome 20 mg daily. Patients can respond well for 10 mg daily and thus consider adjusting the dose depending on the patient. If not achieved symptoms after 4 weeks of treatment with 20 mg of Getzome per day, recommendation to be evaluated.

    Pathological condition increases secretion

    Starting 60 mg/day, the dose increases to 120 mg 3 times/day, daily dose> 80 mg divided into two times.

    Continuing heartburn (≥ twice a week)

    20 mg/day for 14 days.

    Zollinger syndrome - Ellision

    Starting dose: 60 mg omeprazole/day. The dose may vary depending on the individual and the clinical aspect of the treatment should be extended sufficiently as directed.

    The dose may increase to 80 - 120 mg omeprazole/day, with a dose of over 80 mg/day, the dose should be divided 2 times/day.

    Over 90% of patients with serious illness and incomplete response to other therapies can be controlled at a dose of 20 - 120 mg omeprazole per day.

    Children

    Children from 1 year of age and over 10kg

    Treatment of esophagitis due to reflux.

    Treatment of heartburn and acid reflux in patients with gastroesophageal reflux disease. The recommended dose is as follows:

    age

    Weight

    Dosage

    10 - 20 kg

    10 mg per day, can increase to 20 mg per day if necessary.

    ≥ 2 years old

    20 kg

    20 mg per day, the dose may increase to 40 mg daily.

    Weight

    Dosage

    15 - 30 kg

    Getzome 10 mg combined with amoxicillin 25 mg/kg/body weight and clarithromycin 7.5 mg/kg/body weight, use 2 times/day for 1 week.

    31 - 40 kg

    Getzome 20 mg combined with amoxicillin 750 mg and clarithromycin 7.5 mg/kg/body weight, use 2 times/for 1 week.

    40 kg

    Getzome 20 mg combined with amoxicillin 1 g and Clarithromycin 500 mg, used 2 times/day for 1 week.

    No dose adjustment in the elderly.

    Renal failure

    No dose adjustments in patients with renal function.

    Prevention of gastric acid inhalation

    Omeprazole is also used to prevent gastric acid inhalation during body anesthesia. Take the dose of 40 mg in the evening before surgery and add a dose of 40 mg before surgery 2 - 6 hours.

    Liver function failure

    Birth and half -life can increase in patients with liver function, so the dose adjustments need to be adjusted, and the maximum dose is 20 mg/day.

    Patients with difficulty swallowing

    Can pour the medicine in the pupae, swallow separately or share the seeds with a small amount of fruit juice or yogurt after mixing. Can absorb the granules in peanuts and swallow later. It is important not to be crushed or chewed.

    Note: The above dose is for reference only. Specific dosage depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.What do

    do when overdose? No serious symptoms occur when using the oral dosage up to 400 mg. The first thing to remove from the body and do not need any specific therapy.

    What to do when you forget a dose? However, if close to the next dose, skip the forgotten dose and take the next dose at the time as planned. Note that it should not be used double the prescribed dose.

  • Side Effects

    When using Getzome 40, you may experience unwanted effects (ADR).

    Getzome 40 well tolerated, often light side effects and recovery.

  • rash, urticaria and itching, often recovered after stopping the drug. There is also light sensitivity, pimples, diverse roses, Stevens - Johnson syndrome, epidermal necrosis, angioedema and hair loss sometimes occur.
  • Diarrhea, headache may occur, sometimes so severe that it is necessary to stop taking the drug in a small number of patients. In most patients, these symptoms may disappear after treatment.
  • Constipation, nausea, vomiting, flatulence and abdominal pain.
  • dry mouth, stomatitis and gastrointestinal candidiasis also occur in a few cases.
  • Perception, dizziness, mild headache, dizziness, often disappeared when stopping treatment. Insomnia, dizziness has also been reported in a few cases. Confusion, excitement, depression and hallucinations that have happened in serious patients.
  • Arthritis and muscle pain symptoms, often recovered when stopped treatment.
  • In some cases, the following reactions appear: blurred vision, taste disorders, aggressive, peripheral edema, sodium lower blood, sweating, large breast enlargement in men, helplessness, leukopenia, thrombocytopenia, granulocytosis, reduced blood cells, anaphylactic shock, discomfort, fever, bronchitis, severe hepatitis in the patients with severe hepatitis, some patients with hepatitis, severe hepatitis, some patients with severe hepatitis, some patients with severe hepatitis, some patients with hepatitis Few cases of liver failure and interstitial nephritis then lead to acute nephritis.

    Liver enzymes also happened.

    Instructions on how to handle ADR

    When experiencing side effects of the drug, it is necessary to stop using and notify the doctor or go to the nearest medical facility for timely treatment.

    Warnings

    Before using the drug you need to read the instructions carefully and refer to the information below.

    contraindicated

    Getzome 40 drugs contraindicated in the following cases:

  • There is a history of sensitivity to omeprazole.
  • Be cautious when used

    acid in the stomach is reduced in any way, including inhibition of proton pumps can increase the number of permanent bacteria in the stomach, which can lead to a slight increase in the risk of digestive infections such as Salmonella and Campylobacter.

    When suspected stomach ulcers, it is necessary to eliminate malignant ability before starting treatment with Getzome, because the treatment can reduce symptoms and delay diagnosis.

    The ability to drive and operate machinery

    omeprazole does not affect the ability to drive and operate machinery. Side effects of the drug such as dizziness and visual disorders may occur. If affected, patients should not drive or operate machinery.

    Pregnancy

    There is no evidence of Getzome's safety in pregnant women. Animal studies have shown that there is no teratogenic effect, but have shown that the fetal weight is reduced. Avoid use for pregnant women unless there are no safer measures.

    The period of breastfeeding

    There is no report showing that Getzome passes through milk or has an influence on babies. If it is necessary to use Getzome, you should stop breastfeeding.

    Drug interaction

    simultaneously used with omeprazole may reduce the absorption through the stomach of ketoconazole or iTraconazole due to reduced acidic concentration in the stomach.

    Omeprazole can delay the elimination of diazepam, phenytoin and warfarin when used simultaneously because Omeprazole metabolizes through the liver through cytochrome P450.

    The concentration of omeprazole and clarithromycin in plasma increases when used in combination. This is considered a useful interaction in destroying H. Pylori. There is no evidence of the interaction of omeprazole with phenacetin, theophyllline, caffeine, propranolol, metoprolol, cylosporin, lidocaine, quinidine, estradiol, amoxicillin or antacids. Getzome's absorption is not influenced by alcohol or food.

    There is no evidence of interaction with piroxicam, diclofenac or naproxen. This is considered useful when patients need to continue with these treatments.

    Simultaneous coordination of omeprazole and digoxin in healthy people leads to 10% increase in digoxin due to increased pH in the stomach.

    Storage

    Store at temperatures below 30 ° C, avoiding light and moisture.

    Other drugs

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    count views

    Popular Keywords